cancer and hematology Immunotherapy minimizes cancer recurrence risk for Merkel cell carcinoma patient
cancer and hematology Combination therapy offers hope for melanoma patients facing recurrence A melanoma diagnosis can be scary, but when it’s caught and treated early, the estimated five-year survival rate in the U.S. is about 99%. But what if your melanoma is one of the rare melanomas to